CVS
CVS Health Corp. · Healthcare · Medical - Healthcare Plans
Momentum-inputs (vergelijkbare managers):
breedte van houders +3.3% ·
aandelenstroom +0.4% ·
netto nieuwe posities 0.0%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | +1 | 4.62M | $393.86M | +1 | n/a |
| Q2 2026 | 181 | +1 | 951.14M | $98.28B | +4 | −4 |
| Q1 2026 | 184 | -5 | 933.53M | $67.00B | +1 | −7 |
| Q4 2025 | 188 | -1 | 988.04M | $78.39B | +1 | −1 |
| Q3 2025 | 31 | +1 | 672.14M | $50.66B | +1 | −1 |
| Q2 2025 | 28 | +1 | 592.40M | $40.85B | +1 | n/a |
| Q1 2025 | 24 | 0 | 305.08M | $20.66B | +1 | −1 |
| Q4 2024 | 24 | -1 | 290.03M | $13.02B | +1 | −2 |
| Q3 2024 | 24 | +2 | 213.06M | $13.39B | +3 | −1 |
| Q2 2024 | 22 | n/a | 197.40M | $11.65B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 119.84M | -2.3% | $9.03B | 0.2% | ▼ Trim | 2 | SEC ↗ ×22 |
| 2 | The Vanguard Group ✦ (passief) | 118.89M | -1.3% | $8.96B | 0.1% | ▼ Trim | 2 | SEC ↗ ×6 |
| 3 | Dodge & Cox ✦ | 73.18M | -0.1% | $5.52B | 3.0% | ▼ Trim | 6 | SEC ↗ |
| 4 | JPMorgan Chase ✦ | 70.55M | n/a | $5.32B | 0.2% | n/c | 1 | SEC ↗ ×42 |
| 5 | Capital World Investors ✦ | 68.38M | +2.1% | $5.16B | 0.7% | ▲ Add | 6 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (passief) | 58.94M | +0.2% | $4.44B | 0.2% | ▲ Add | 4 | SEC ↗ |
| 7 | Fidelity (FMR) ✦ | 43.34M | -5.0% | $3.27B | 0.2% | ▼ Trim | 2 | SEC ↗ ×7 |
| 8 | Geode Capital Management ✦ (passief) | 28.99M | +1.2% | $2.18B | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | Morgan Stanley ✦ | 19.16M | n/a | $1.44B | 0.1% | n/c | 1 | SEC ↗ ×19 |
| 10 | T. Rowe Price ✦ | 17.40M | +4.7% | $1.31B | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 11 | Glenview Capital ✦ | 8.20M | 0.0% | $617.96M | 15.0% | Held | 6 | SEC ↗ |
| 12 | Goldman Sachs Group ✦ | 7.16M | n/a | $540.10M | 0.1% | n/c | 1 | SEC ↗ ×5 |
| 13 | Wellington Management ✦ | 6.33M | +391.6% | $477.27M | 0.1% | ▲ Add | 6 | SEC ↗ ×8 |
| 14 | Millennium Management ✦ | 5.38M | +32.2% | $405.46M | 0.3% | ▲ Add | 6 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 5.29M | +70.5% | $399.12M | 0.3% | ▲ Add | 6 | SEC ↗ |
| 16 | Marshall Wace ✦ | 3.66M | +111.3% | $276.28M | 0.3% | ▲ Add | 6 | SEC ↗ ×2 |
| 17 | Citadel Advisors ✦ | 3.22M | -60.6% | $242.54M | 0.2% | ▼ Trim | 6 | SEC ↗ ×2 |
| 18 | AQR Capital Management ✦ | 3.05M | +34.0% | $230.15M | 0.1% | ▲ Add | 6 | SEC ↗ ×7 |
| 19 | Fairfax Financial ✦ | 2.71M | 0.0% | $204.38M | 9.9% | Held | 4 | SEC ↗ |
| 20 | PRIMECAP Management ✦ | 2.67M | -8.8% | $201.43M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 21 | Adage Capital Partners ✦ | 1.87M | +16.3% | $141.08M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 1.19M | +42.6% | $89.95M | 0.4% | ▲ Add | 6 | SEC ↗ |
| 23 | D. E. Shaw & Co. ✦ | 1.12M | +20.6% | $84.30M | 0.1% | ▲ Add | 6 | SEC ↗ ×3 |
| 24 | Harris Associates (Oakmark) ✦ | 548.57K | -35.0% | $41.36M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 25 | Point72 Asset Management ✦ | 426.09K | Nieuw | $32.12M | 0.1% | New | 1 | SEC ↗ |
| 26 | Gotham Asset Management ✦ | 236.00K | +33.8% | $17.79M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 27 | Renaissance Technologies ✦ | 160.90K | -72.4% | $12.13M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 28 | GAMCO Investors ✦ | 127.48K | -3.3% | $9.61M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 29 | Fisher Asset Management ✦ | 89.10K | -5.3% | $6.72M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 30 | Two Sigma Investments ✦ | 23.07K | +1.7% | $1.74M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 31 | Tweedy, Browne ✦ | 10.36K | +104.6% | $780,814 | 0.1% | ▲ Add | 2 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Point72 Asset Management | $32.12M | 0.1% |
Verlaten
| Norges Bank | $1.36B | was 0.2% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,848 houders, 1.07B aandelen, $73.55B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.